Merck Recalls HIB Vaccines In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Merck recalled more than 100,000 doses of its HIB vaccines exported to China, as part of its global initiative to recall certain lots of PedvaxHIB and Comvax vaccines due to sterilization concerns